Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

24. Dezember 2025 bis 1. Januar 2026: Die Deutsche Nationalbibliothek bleibt an beiden Standorten geschlossen. // 24 December 2025 to 1 January 2026: The German National Library will be closed at both locations.

Ergebnis der Suche nach: "James" and "Pugh"
im Bestand: Gesamter Bestand

1 - 10 von 70

	1	Albi grade enables risk stratification for bleeding events and refines prognostic prediction in advanced HCC following atezolizumab and bevacizumab Stefanini, Bernardo. - Freiburg : Universität, 2025
	2	Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab Scheiner, Bernhard. - Freiburg : Universität, 2025
	3	Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours Celsa, Ciro. - Freiburg : Universität, 2023
	4	Contemporary challenges in education Münster : Waxmann, 2023
	5	One Health assessment of persistent organic chemicals and PFAS for consumption of restored anadromous fish Enthalten in Journal of exposure science & environmental epidemiology 15.12.2023: 1-10
	6	Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study D’Alessio, Antonio. - Freiburg : Universität, 2022
	7	Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study Fulgenzi, Claudia Angela Maria. - Freiburg : Universität, 2022
	8	Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma Enthalten in Liver cancer Bd. 11, 2022, Nr. 4: 354-367. 14 S.
	9	Deserteur Delano, Jamie. - Mannheim : Dantes Verlag, Mai 2021, Erste Auflage
	10	Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma Fessas, Petros. - Freiburg : Universität, 2021